Trinity Biotech plc (TRIB)

CIK 0000888721 · Healthcare · Medical Devices

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest FY-2025 —
FY-2024 —
FY-2023
FY-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Document and Entity Information
—
Statements
Consolidated Statement of Operations
—
Consolidated Statement of Comprehensive Income
—
Consolidated Statement of Financial Position
—
Consolidated Statement of Changes In Equity
—
Consolidated Statement of Cash Flows
—
Notes
(loss)/earnings Per Share
—
(loss)/profit For The Year On Discontinued Operations
—
Accounting Estimates and Judgements
—
Authorisation For Issue
—
Basis of Preparation and Significant Accounting Policies
—
Business Combinations
—
Capital and Financial Risk Management
—
Capital and Reserves
—
Cash and Cash Equivalents
—
Commitments and Contingencies
—
Cybersecurity Risk Management and Strategy Disclosure
—
Deferred Tax Assets and Liabilities
—
Employment
—
Financial Assets
—
Financial Income and Expenses
—
Goodwill and Intangible Assets
—
Group Undertakings
—
Impairment Charges
—
Impairment, Restructuring and Once Off Costs
—
Impairment, Transformation and Once Off Costs
—
Income Tax (expense)/credit
—
Income Tax Credit
—
Insider Trading Policies and Procedures
—
Interest-bearing Loans and Borrowings
—
Inventories
—
Lease Liabilities
—
Loss Before Tax
—
Loss Per Share
—
Other Non-current Assets
—
Other Operating (expense) / Income
—
Other Operating Income
—
Other Operating Income / (expense)
—
Post Balance Sheet Events
—
Profit For The Year On Discontinued Operations
—
Property, Plant and Equipment
—
Provisions
—
Reconciliation of Liabilities Arising From Financing Activities
—
Related Party Transactions
—
Segment Information
—
Share Options
—
Trade and Other Payables
—
Trade and Other Receivables
—